Guggenheim Investments Announces October 2013 Closed-End

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Guggenheim Investments Announces October 2013 Closed-End Fund Distributions

NEW YORK, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the "Funds" and each, a "Fund").

The following dates apply to the distributions:

Record Date October 15, 2013
Ex-Dividend Date October 11, 2013
Payable Date October 31, 2013
 
Distribution Schedule
NYSE Ticker Closed-End Fund Name Distribution
Per Share
Change from
Previous Distribution
Frequency
AGC Advent Claymore Convertible Securities and Income Fund II $0.04700   Monthly
AVK Advent Claymore Convertible Securities and Income Fund $0.09390   Monthly
GBAB Guggenheim Build America Bonds Managed Duration Trust $0.13817   Monthly
GEQ Guggenheim Equal Weight Enhanced Equity Income Fund $0.43750   Quarterly
GGM Guggenheim Credit Allocation Fund $0.16146   Monthly
GOF Guggenheim Strategic Opportunities Fund $0.18210   Monthly
MZF Managed Duration Investment Grade Municipal Fund  $0.07350   Monthly
WIA Western Asset/Claymore Inflation-Linked Securities & Income Fund $0.03200   Monthly
WIW Western Asset/Claymore Inflation-Linked Opportunities & Income Fund $0.03350   Monthly

Past performance is not indicative of future performance. As of this announcement, the sources of each fund distribution are estimates. Distributions may be paid from sources of income other than ordinary income, such as short term capital gains, long term capital gains or return of capital. If a distribution consists of something other than ordinary income, Shareholders of record, as of the applicable record date, will be sent a Section 19(a) notice with the anticipated source(s) of the distribution. Section 19(a) notices are provided for informational purposes only and not for tax reporting purposes. The final determination of the source and tax characteristics of all distributions in 2013 will be made after the end of the year. This information is not legal or tax advice. Consult a professional regarding your specific legal or tax matters.

About Guggenheim Investments

Guggenheim Investments represents the investment management division of Guggenheim Partners, LLC ("Guggenheim"), which consists of investment managers with approximately $151 billion in combined total assets*. Collectively, Guggenheim Investments has a long, distinguished history of serving institutional investors, ultra-high-net-worth individuals, family offices and financial intermediaries. Guggenheim Investments offers clients a wide range of differentiated capabilities built on a proven commitment to investment excellence. Guggenheim Investments has offices in Chicago, New York City and Santa Monica, along with a global network of offices throughout the United States, Europe, and Asia.

Guggenheim Investments is comprised of several investment management entities within Guggenheim, which includes Guggenheim Funds Distributors, LLC and Guggenheim Funds Investment Advisors, LLC (together, "Guggenheim Funds"). Guggenheim Funds Investment Advisors, LLC serves as Investment Adviser for AGC , GBAB , GEQ , GGM , GOF and WIW . Guggenheim Funds Distributors, LLC serves as Servicing Agent for AVK , MZF and WIA . The Investment Advisers for AVK , MZF and WIA are Advent Capital Management, LLC, Cutwater Investor Services Corporation and Western Asset Management Company, respectively.

*The total asset figure is as of 6.30.2013 and includes $11.720B of leverage and $0.331B of leverage for Serviced Assets. AUM includes assets from Security Investors, Guggenheim Partners Investment Management, LLC, Guggenheim Funds Investment Advisors and its affiliated entities, and some business units including Guggenheim Real Estate, Guggenheim Aviation, GS GAMMA Advisors, Guggenheim Partners Europe, Transparent Value Advisors, and Guggenheim Partners India Management. Values from some funds are based upon prior periods.

This information does not represent an offer to sell securities of the Funds and it is not soliciting an offer to buy securities of the Funds. There can be no assurance that the Funds will achieve their investment objectives. Investments in the Funds involve operating expenses and fees. The net asset value of the Funds will fluctuate with the value of the underlying securities. It is important to note that closed-end funds trade on their market value, not net asset value, and closed-end funds often trade at a discount to their net asset value. Past performance is not indicative of future performance. An investment in closed-end funds is subject to investment risk, including the possible loss of the entire amount that you invest. Some general risks and considerations associated with investing in a closed-end fund include: Investment and Market Risk; Lower Grade Securities Risk; Equity Securities Risk; Foreign Securities Risk; Interest Rate Risk; Illiquidity Risk; Derivative Risk; Management Risk; Anti-Takeover Provisions; Market Disruption Risk and Leverage Risk. In addition, MZF is subject to AMPS Risk. See www.guggenheiminvestments.com/cef for a detailed discussion of fund-specific risks.

Investors should consider the investment objectives and policies, risk considerations, charges and expenses of any investment before they invest. For this and more information visit www.guggenheiminvestments.com or contact a securities representative or Guggenheim Funds Distributors, LLC 2455 Corporate West Drive, Lisle, IL 60532, 800-345-7999.

NOT FDIC-INSURED | NOT BANK-GUARANTEED | MAY LOSE VALUE
Member FINRA/SIPC (10/13)

Analyst Inquiries William T. Korver 630.505.3700 Media Inquiries Jeaneen Pisarra 212.518.5367

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 9

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 17

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 13

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 20

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 19

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 16

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 17

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 11

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Zeta Global Faces Class Action Risks

Updated Category News Views 124

Understanding the Zeta Global Class Action Lawsuit Zeta Global Holdings Corp. finds itself at a pivotal moment as investors are encouraged to take action following significant losses related to the company's stock performance. This situation arises from allegations concerning misleading practices during a specified class period. Investors who purchased or acquired Zeta...

Continue Reading
Belk and Sewing Down South Unveil Exciting Seasonal Collection

Updated Category News Views 592

Belk Introduces Collaborations for Summer and Holiday Lines Belk, a prominent name in department stores, is excited to announce its new partnership with Sewing Down South, a vibrant lifestyle brand founded by Craig Conover. This collaboration is set to redefine Southern fashion, providing customers with an array of stylish options for both summer and the upcoming holiday...

Continue Reading
Explore the Ongoing Securities Investigation of Construction Partners

Updated Category News Views 198

Understanding the Securities Fraud Investigation of Construction Partners, Inc. The Law Offices of Frank R. Cruz are currently conducting an investigation into Construction Partners, Inc. (NASDAQ: ROAD). This inquiry focuses on potential violations of federal securities laws that may have had adverse effects on investors. If you are among those who suffered financial...

Continue Reading
eHealth, Inc. Announces Q3 2025 Earnings Call Details

Updated Category News Views 111

eHealth, Inc. to Share Third Quarter Earnings on November 5 eHealth, Inc. (NASDAQ: EHTH), recognized as a leading private online health insurance marketplace, is gearing up to unveil its financial results for the third quarter of 2025. The announcement is scheduled for November 5, when eHealth will provide comprehensive insights into its performance for investors and...

Continue Reading
Danske Mortgage Bank Set to Release Annual Report Soon

Updated Category News Views 107

Danske Mortgage Bank Plc's Upcoming Annual Report Release Danske Mortgage Bank Plc is gearing up to unveil its much-anticipated annual report for 2025 on a scheduled date that reflects the company's commitment to transparency and financial reporting. This report serves as an essential tool for stakeholders, investors, and analysts who follow the financial performance and...

Continue Reading